Faeth Therapeutics to host virtual KOL event on endometrial cancer multi-nodal inhibition

PUBT · 1d ago
Faeth Therapeutics to host virtual KOL event on endometrial cancer multi-nodal inhibition
  • Faeth Therapeutics will host a virtual key opinion leader event on Oct. 6, 2026 at 10:00 a.m. ET.
  • Discussion to focus on multi-nodal inhibition of the PI3K/AKT/mTOR pathway in endometrial cancer.
  • Management plans to review the PIKTOR regimen combining serabelisib with sapanisertib.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Faeth Therapeutics Inc published the original content used to generate this news brief via Business Wire (Ref. ID: 20260908009769) on September 08, 2026, and is solely responsible for the information contained therein.